top of page

Biopharma Daily Stock Updates - 08/18/21

$XBI $122 -2%


Pipeline Updates

$LQDA -2% No Form 483 observations were issued during 5-day inspection. source

$PRTK +1% Announces FDA Orphan Drug Designation for NUZYRA® (omadacycline) for the Treatment of Infections Caused by Nontuberculous Mycobacteria. source

$ANIX +9% Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology. source

$CLRB -1% Awarded $2.0 Million Phase II NIH SBIR Grant to Support Pivotal Study of Iopofosine I-131 in Waldenstrom’s Macroglobulinemia. source

$CRTX -1% Cortexyme to Present at Annual Biomarkers for Alzheimer’s Disease Summit. source

$GLTO +1% First Patient Treated in Phase 2a Trial of the Oral LOXL2 Inhibitor GB2064 in Myelofibrosis (the MYLOX-1 Trial). source

$ASMB +3% Assembly Bio Selects Fourth HBV Core Inhibitor Candidate for Advancement Into Clinical Development. source

$STRO -2% Sutro Biopharma Announces STRO-002 FDA Fast Track Designation for Patients with Advanced Ovarian Cancer. source

$CABA +10% Clinical Data from the Second Dose Cohort in DesCAARTes™ Trial in Patients with mPV. source


Posted by DV

bottom of page